The Global Diagnostics Market report, analyzed by Astute Analytica, examines the tuberculosis, asthma, sepsis, and pneumonia diagnostics market for the study period 2017-2030.
The Global Tuberculosis Diagnostics Market is projected to reach US$ 4,480.7 Mn by 2030 from US$ 2,984.8 Mn in 2021, registering a CAGR of 4.7% during 2022-2030.
The Global Asthma Diagnostics Market was valued at US$ 3,385.5 Mn in 2021 and is forecasted to reach US$ 5,857.7 Mn by 2030, registering a CAGR of 6.5% over the projection period.
The Global Sepsis Diagnostics Market is witnessing a CAGR of 8.4% during 2022-2030. The Sepsis Diagnostics Market is estimated to witness a growth in its revenue from US$ 489.3 Mn in 2021 to US$ 992.8 Mn by 2030. Further, the Global Pneumonia Diagnostics Market is anticipated to experience a leap forward in its revenue from US$ 460.9 Mn in 2021 to US$ 828.5 Mn by 2030, recording a growth rate of 6.9% over the forecast period. The diagnostics market is majorly driven by factors such as an increase in prevalence of chronic and infectious diseases and availability of point-of-care testing kits.
Infectious diseases are on the rise across the world. According to WHO (World Health Organization), a total of 1.5 million people died from TB in 2020. Worldwide, TB is the 13th leading cause of death and the second leading infectious killer after COVID-19. TB occurs in every part of the world. In 2020, the largest number of new TB cases occurred in the WHO South-East Asian region, with 43% of new cases, followed by the WHO African region, with 25% of new cases. Further, asthma is a major non-communicable disease affecting both children and adults. According to the data presented by WHO, asthma affected an estimated 262 million people in 2019 and caused 4,55,000 deaths. Sepsis is a syndromic response to infection and is frequently a final common pathway to death from many infectious diseases worldwide. According to recent studies, sepsis kills 11 million people each year, many of them children. It disables millions more. In addition, Pneumonia is the single largest infectious cause of death in children worldwide. Pneumonia accounts for 14% of all deaths of children under 5 years old in 2019. Moreover, the availability of point of care testing kits such as lateral flow assays is propelling the market growth. However, stringent regulatory approvals may affect market growth.
Asia Pacific holds the highest share of the Global Tuberculosis Diagnostics Market and registers the highest CAGR over the forecast period. This is because the Asia-Pacific region carries the highest share of the global TB burden, including the majority of all estimated multidrug-resistant (MDR)-TB cases. Further, in terms of test type, the diagnostic laboratory method holds the highest market share in 2021. The usage of new technologies like fluorescent microscopy, and liquid cultures for identification and drug sensitivity has made the diagnosis, identification, and drug sensitivity tests fast and reliable, which makes this segment hold the highest share.
The asthma diagnostic market is registering a CAGR of 6.5% over the forecast period. Based on type, allergy tests hold the highest market share in 2021 as they are quick, reliable, and cost-effective. Allergy tests are a way to get to the bottom of what's causing asthma symptoms. Further, in terms of end-users, hospitals are the highest end-users in the asthma diagnostics market in 2021. The Asia Pacific is the highest shareholder region in the Global Asthma Diagnostics Market in 2021.
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. If not recognized early and managed promptly, it can lead to septic shock, multiple organ failure, and death. North America is the highest shareholder region in the Global Sepsis Diagnostics Market in 2021 whereas Asia Pacific records the highest CAGR over the forecast period. This is because in low- and middle-income countries sepsis represents a major cause of maternal and neonatal morbidity and mortality. In terms of test type, the CRP test holds the highest segmental share in 2021 as CRP is an acute phase reactant and a sensitive biomarker for sepsis.
Blood test holds the highest share in the pneumonia diagnostics market in 2021 as it is one of the initial and common ways to determine the cause of pneumonia in a patient. The segment also registers the highest CAGR over the forecast period. Further, in terms of end-users, hospitals are the highest end-users in the pneumonia diagnostics market in 2021. Further, North America holds the highest market share in 2021.
The key players in the Global Diagnostics Market are Abbott Laboratories, Thermo Fisher Scientific Inc., Becton Dickenson, Koninklijke Philips N.V., and BioMerieux, among others.
The following are the various segmentation of the Global Diagnostics Market:
By Test Type segment of the Global Tuberculosis Diagnostics Market is sub-segmented into:
By End User segment of the Global Tuberculosis Diagnostics Market is sub-segmented into:
By Test Type segment of the Global Asthma Diagnostics Market is sub-segmented into:
By End User segment of the Global Asthma Diagnostics Market is sub-segmented into:
By Test Type segment of the Global Sepsis Diagnostics Market is sub-segmented into:
By End User segment of the Global Sepsis Diagnostics Market is sub-segmented into:
By Test Type segment of the Global Pneumonia Diagnostics Market is sub-segmented into:
By End User segment of the Global Pneumonia Diagnostics Market is sub-segmented into:
The various markets covered under the global diagnostics market report are the tuberculosis diagnostics market, asthma diagnostics market, sepsis diagnostics market, and pneumonia diagnostics market.
Global Tuberculosis Diagnostics Market was valued at US$ 2,984.8 Mn in 2021.
The Global Asthma Diagnostics Market was valued at US$ 3,385.5 Mn in 2021.
Sepsis diagnostic market holds the highest growth rate over the projection period.
Global Asthma Diagnostics Market holds the highest market share in 2021.
The diagnostics market is majorly driven by factors such as an increase in the prevalence of chronic and infectious diseases and the availability of point-of-care testing kits.
Stringent regulatory approval may hinder market growth.
Blood Test holds the highest share in the Global Pneumonia Diagnostics Market.
Hospitals are the highest end-users in the Global Diagnostics Market.
Asia Pacific holds the highest share in the Global Tuberculosis Diagnostics Market.
North America holds the highest share in the Global Sepsis Diagnostics Market.
The key players in the Global Diagnostics Market are Abbott Laboratories, Thermo Fisher Scientific Inc., Becton Dickenson, Koninklijke Philips N.V., and BioMerieux, among others.
LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.
SPEAK TO AN ANALYST
.png)
Features | Type of License | |||
 Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 2-6 Users | Unlimited within Company/Enterprise | |
⨉ | ⨉ | ✓ | ||
Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ✓ | ✓ | ✓ |
| ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ✓ | |
Analyst Support | 4 Month Post purchase | 7 Month Post purchase | One Year Post purchase | |
Free Report update in next update cycle | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ✓ | |
Benefit | Up to 20% off on next purchase | Up to 30% off on next purchase | Up to 40% off on next purchase | |
| Report ID: AA0522240 | Delivery: 2 to 4 Hours 
.svg)
